1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease : An Open-Label Phase 2a Study
(
- Contribution to journal › Article
-
Mark
Authors' Reply : Endopeptidase Therapy for Anti-Glomerular Basement Membrane Disease: Beware of Anti-Hinge Antibodies!
(
- Contribution to journal › Letter
- 2019
-
Mark
The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane disease
(
- Contribution to journal › Article
- 2018
-
Mark
Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients
(
- Contribution to journal › Article
-
Mark
Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS
(
- Contribution to journal › Article
- 2015
-
Mark
Size-dependent lymphatic uptake of nanoscale-tailored particles as tumor mass increases
(
- Contribution to journal › Article
- 2006
-
Mark
Chemokine-directed migration of tumor-inhibitory neural progenitor cells towards an intracranially growing glioma.
(
- Contribution to journal › Article
-
Mark
Polychlorinated biphenyl load, aryl hydrocarbon receptor, and cytochrome P4501A1 induction in a wild population of Atlantic salmon (Salmo salar) from the Baltic Sea
(
- Contribution to journal › Article
- 2004
-
Mark
Identification and characterization of a human smad3 splicing variant lacking part of the linker region.
(
- Contribution to journal › Article
-
Mark
Neural progenitor cell lines inhibit rat tumor growth in vivo.
(
- Contribution to journal › Article